XLO ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥8/12/2026
EPSå®çžŸïŒUSDïŒ-0.33
売äžé«å®çžŸïŒUSDïŒ18.69M
Xilio Therapeutics Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Xilio Therapeutics Inc ã®æ±ºç®å ±åæžã次å Xilio Therapeutics Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãXilio Therapeutics Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Xilio Therapeutics Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
XLO 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
XLO FY2025 決ç®
EPS (å幎åææ¯)-4.1972.49%
売äžé« (å幎åææ¯)43.77M589.88%
Xilio Therapeutics IncïŒXLOïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 8/12/2026 | 06/2026 | -0.33/-0.59 | 18.69M/12.72M | 44.33% | 46.95% |
| 5/12/2026 | 03/2026 | -0.58/-0.66 | 12.65M/8.52M | 11.68% | 48.45% |
| 3/23/2026 | 12/2025 | 0.95/-1.68 | 13.69M/7.96M | 156.76% | 71.93% |
| 11/13/2025 | 09/2025 | -0.11/-0.42 | 19.07M/18.64M | 73.09% | 2.31% |
| 8/14/2025 | 06/2025 | -0.16/-1.12 | 8.08M/8.21M | 85.33% | -1.53% |
| 5/8/2025 | 03/2025 | -0.18/1.33 | 2.93M/4.40M | -113.35% | -33.41% |
| 3/11/2025 | 12/2024 | -0.20/-3.03 | 1.72M/3.30M | 93.33% | -47.76% |
| 11/7/2024 | 09/2024 | -0.22/-0.25 | 2.26M/3.30M | 10.44% | -31.42% |